Clinical Trial Update: Colchicine and Post-COVID-19 Pulmonary Fibrosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update investigating colchicine for post-COVID-19 pulmonary fibrosis (interstitial pulmonary fibrosis).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Fibrosis

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: ClinAmygate | Conditions: Covid19, Pulmonary Fibrosis Interstitial | Phase 4 | Status: UNKNOWN